[{"id":"abcc9d45-86e5-4f8d-9765-fdc49b92af3e","acronym":"","url":"https://clinicaltrials.gov/study/NCT06028074","created_at":"2023-09-07T16:09:55.474Z","updated_at":"2025-02-25T15:20:49.574Z","phase":"Phase 1/2","brief_title":"Safety and Tolerability Study of GIM-122 in Subjects With Advanced Solid Malignancies","source_id_and_acronym":"NCT06028074","lead_sponsor":"Georgiamune Inc","biomarkers":" LAG3","pipe":"","alterations":" ","tags":["LAG3"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e GIM-122"],"overall_status":"Recruiting","enrollment":" Enrollment 111","initiation":"Initiation: 12/12/2023","start_date":" 12/12/2023","primary_txt":" Primary completion: 09/01/2026","primary_completion_date":" 09/01/2026","study_txt":" Completion: 12/01/2026","study_completion_date":" 12/01/2026","last_update_posted":"2025-02-12"}]